UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): November 20, 2006


                              POSSIS MEDICAL, INC.
             (Exact name of registrant as specified in its charter)


         Minnesota                      0-944                    41-0783184
(State or other jurisdiction    (Commission File Number)        (IRS Employer
    of incorporation)                                        Identification No.)


9055 Evergreen Boulevard NW, Minneapolis, MN                         55433-8003
(Address of principal executive offices)                             (Zip Code)


Registrant's telephone number, including area code: 763-780-4555


                                 Not Applicable
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]     Written communications pursuant to Rule 425 under the Securities Act
        (17 CFR 230.425)

[ ]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act
        (17 CFR 240.14a-12)

[ ]     Pre-commencement communications pursuant to Rule 14d-2(b) under the
        Exchange Act (17 CFR 240.14d-2(b))

[ ]     Pre-commencement communications pursuant to Rule 13e-4(c) under the
        Exchange Act (17 CFR 240.13e-4(c))



Item 7.01 - Regulation FD Disclosure

On November 20, 2006, Possis Medical, Inc., announced they will be participating
in the Lazard Capital Markets Life Sciences Conference at the New York Palace
Hotel on Wednesday, November 29th, 2006. A copy of the press release is
furnished as Exhibit 99.1 to this Report.

Item 9.01 Financial Statements and Exhibits

        [c]     Exhibits

        99.1    Press Release, dated November 20, 2006, issued by Possis
                Medical, Inc.


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Possis Medical, Inc.
(Registrant)

Date:   November 20, 2006


By:     /s/
        Jules L. Fisher
        Vice President, Finance and Chief Financial Officer




                                  EXHIBIT INDEX

Exhibit No.     Description
- -----------     -----------
99.1            Press Release, dated November 20, 2006, issued by Possis
                Medical, Inc.